CD44 and neoplasm: More recently, it was observed that the transmembrane glycoprotein CD44, a cancer stem cell (CSC) marker, which is also associated with EMT, regulates the expression of TF in breast cancer cells, resulting in enhanced tumor cell procoagulant activity and metastatic dissemination [19].